ATM gene's contribution to breast cancer risk was previously evaluated in the context of high-risk families, in BRCA1/2 mutation carriers, and in average risk populations (reviewed in Gatti et al, 1999; Hall, 2005). This evidence concerns the gene ATM and breast carcinoma.